BMEA
NASDAQ
$1.31
Biomea Fusion Inc (BMEA)
Biomea Fusion, Inc., a biopharmaceutical company, is focused on the discovery, development and commercialization of irreversible small molecules to treat patients with genetically defined cancers. The company is headquartered in Redwood City, California.
Sector:
Healthcare
Industry:
Biotechnology
Buy
Target: $6.83 (+421.37%)
Market Cap
$93M
FCF 5Y CAGR
+46.34%
Free Cash Flow Yield
-60.44%
Beta (5Y)
1.52
Price Chart
Valuation
Market Cap$93M
P/B4.96
Profitability
EBITDA-$66M
Profit Margin2.4%
Operating Margin2.5%
EPS-$0.74
Financial Health
Free Cash Flow Yield-60.44%
Growth & Risk
FCF 5Y CAGR+46.34%
Beta (5Y)1.52
Sharpe Ratio-0.00